4//SEC Filing
WADE JEFFREY L 4
Accession 0001127602-24-007628
CIK 0001062822other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 4:32 PM ET
Size
15.6 KB
Accession
0001127602-24-007628
Insider Transaction Report
Form 4
WADE JEFFREY L
EVP, Gen. Counsel
Transactions
- Exercise/Conversion
Common Stock
2024-02-28+49,113→ 361,905 total - Tax Payment
Common Stock
2024-02-28$2.62/sh−37,691$98,750→ 324,214 total - Exercise/Conversion
Restricted Stock Units
2024-02-28−11,177→ 0 total→ Common Stock (11,177 underlying) - Exercise/Conversion
Restricted Stock Units
2024-02-28−37,274→ 37,273 total→ Common Stock (37,274 underlying) - Exercise/Conversion
Common Stock
2024-02-28+37,274→ 312,792 total - Exercise/Conversion
Restricted Stock Units
2024-02-28−49,113→ 98,227 total→ Common Stock (49,113 underlying) - Exercise/Conversion
Common Stock
2024-02-28+11,177→ 275,518 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001225767
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 4:32 PM ET
- Size
- 15.6 KB